Blackstone Inc
TXG icon

Blackstone Inc’s 10x Genomics TXG Stock Holding History

Blackstone Inc’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,485
Closed -$193K – 306
2025
Q3 		$193K Hold
16,485
– – ﹤0.01% 241
2025
Q2 		$191K Hold
16,485
– – ﹤0.01% 162
2025
Q1 		$144K Hold
16,485
– – ﹤0.01% 165
2024
Q4 		$237K Hold
16,485
– – ﹤0.01% 154
2024
Q3 		$372K Hold
16,485
– – ﹤0.01% 148
2024
Q2 		$321K Hold
16,485
– – ﹤0.01% 160
2024
Q1 		$619K Hold
16,485
– – ﹤0.01% 150
2023
Q4 		$923K Hold
16,485
– – ﹤0.01% 116
2023
Q3 		$680K Hold
16,485
– – ﹤0.01% 129
2023
Q2 		$921K Hold
16,485
– – ﹤0.01% 126
2023
Q1 		$920K Buy
16,485
+9,019
+121% +$421K ﹤0.01% 123
2022
Q4 		$272K Buy
+7,466
New +$244K ﹤0.01% 151

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Blackstone Inc's TXG Position: Q4 2025 in Review

Blackstone Inc sold out of 10x Genomics (TXG) in Q4 2025, closing a stake of 16,485 shares — an estimated $193K sold.

Blackstone Inc first reported a position in TXG in Q4 2022 and held it in 12 quarters. The position peaked at $923K in Q4 2023. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

  • Blackstone Inc reported no remaining 10x Genomics position as of Q4 2025 after selling out during the quarter.
  • Blackstone Inc sold 16,485 10x Genomics shares in Q4 2025, an estimated $193K.
  • Blackstone Inc first reported a position in 10x Genomics in Q4 2022 and held it in 12 quarters.
  • Blackstone Inc's 10x Genomics position peaked at $923K in Q4 2023.
  • 322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on Blackstone Inc's 13F filing for Q4 2025, filed 17 Feb 2026.